Respiratory Syncytial Virus Infections

02/01/1984 - "Ribavirin aerosol therapy also has proven effective to reduce symptoms of respiratory syncytial virus infections in young adults and hospitalized neonates. "
04/01/2014 - "Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients."
04/15/2006 - "As the use of aerosolized ribavirin to treat respiratory syncytial virus infections continues, it is imperative that careful attention be paid to possible adverse effects of therapy in the high-risk population of immunosuppressed patients."
02/01/1998 - "[Respiratory syncytial virus infections and ribavirin: the controversy continues]."
03/01/1996 - "Aerosolized ribavirin is administered frequently to treat severe respiratory syncytial virus infections. "

11/15/2014 - "Increasing evidence on the successful use of ribavirin (alone or in combination with immunomodulators) for the treatment of respiratory syncytial virus infections in HM patients and HCT recipients is available from retrospective studies; however, prospective clinical trials are necessary to establish its efficacy with confidence. "
01/01/2012 - "Data on the successful use of ribavirin, with or without immunomodulators, for respiratory syncytial virus infections in HCT recipients has emerged over the past 2 decades but is still controversial at best because of a lack of randomized controlled trials. "

04/01/2014 - "Breakthrough respiratory syncytial virus infections occurred in 2.2%, demonstrating good efficacy of palivizumab in this population compared with the original, multi-centre, randomised trial."
01/01/2015 - "Palivizumab is indicated as a prophylactic treatment against respiratory syncytial virus infections in children with hemodynamically significant CHD. "
09/01/2014 - "Nosocomial respiratory syncytial virus infections in the palivizumab-prophylaxis era with implications regarding high-risk infants."
06/01/2014 - "During the prophylaxis period, low frequency of respiratory syncytial virus infections and low rates of hospitalization were observed, suggesting the benefit of palivizumab prophylaxis."
12/01/2009 - "From the American Academy of Pediatrics: Policy statements--Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections."

03/01/1997 - "Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group."
05/01/2001 - "In this article, the author presents a review about novel approaches to the prevention of respiratory syncytial virus infections, such as: passive immunization with human polyclonal intravenous immune globulin and humanized monoclonal antibodies (both already licensed for use in premature infants and children with bronchopulmonary dysplasia), and many different vaccines that are potential candidates for active immunization against respiratory syncytial virus."

07/01/1993 - "Severity of respiratory syncytial virus infections and immunoglobulin concentrations."
12/01/1987 - "Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children."
10/01/2003 - "Of the 131 non-fatal cases, 3 had concomitant infections (respiratory syncytial virus bronchiolitis, right-sided pneumonia, Haemophilus influenzae type b meningitis), 2 had aseptic meningitis, and 1 each had transient drowsiness, intravenous immunoglobulin-related complications and transverse myelitis. "
08/01/2001 - "Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins."

01/01/2012 - "The prophylaxis and treatment with antiviral agents of respiratory syncytial virus infections."
04/01/2000 - "Antiviral drugs are now available against influenza virus and respiratory syncytial virus infections. "
02/15/2003 - "Antiviral drugs in the immunocompetent host: part II. Treatment of influenza and respiratory syncytial virus infections."
07/01/2001 - "This review focuses on the activity, clinical pharmacology, and clinical indications of antiviral agents used in the management of influenza, respiratory syncytial virus infections, and chronic hepatitis B and C. "

01/01/2012 - "Antibodies for prevention and treatment of respiratory syncytial virus infections in children."
12/01/2010 - "Serum antibodies critically affect virus-specific CD4+/CD8+ T cell balance during respiratory syncytial virus infections."
04/01/1993 - "Evaluation of immunoglobulin E-specific antibodies and viral antigens in nasopharyngeal secretions of children with respiratory syncytial virus infections."
12/01/1989 - "IgG and IgM antibodies to viral glycoproteins in respiratory syncytial virus infections of graded severity."

01/01/1980 - "The immunoperoxidase antibody (IPA) technique was used to develop two new tests for serodiagnosis of respiratory syncytial virus infections: a microneutralization test based on the reduction of the number of infected cells and an IPA test for determination of virus-specific immunoglobulin G (IgG). "
01/01/1980 - "Both IPA-IgG and neutralization test (in the presence of complement) appear very efficient in serologically detecting respiratory syncytial virus infections in infants older than 1 month and give rapid results (IPA-IgG takes 2 h to complete, and the neutralization test takes 24 h). "
07/01/1993 - "In a prospective study in 86 children with respiratory syncytial virus infections, no relation was detected between the severity of infection (based on diagnosis, chest radiography findings, need for mechanical ventilation, and duration of hospitalisation) and serum concentrations of IgG, IgA, IgM, and IgG1-4 on admission."
12/01/1989 - "IgG and IgM antibodies to viral glycoproteins in respiratory syncytial virus infections of graded severity."

08/01/1971 - "[Comparative studies with the neutralization test and complement fixation test in the diagnosis of respiratory syncytial virus infections]."
07/01/2000 - "Mycoplasma pneumoniae, influenza A and B, adenovirus, and respiratory syncytial virus infections were diagnosed by >/=4-fold increases in complement fixation titer or a single high titer (>/=64). "
01/01/1980 - "Both IPA-IgG and neutralization test (in the presence of complement) appear very efficient in serologically detecting respiratory syncytial virus infections in infants older than 1 month and give rapid results (IPA-IgG takes 2 h to complete, and the neutralization test takes 24 h). "

11/01/2012 - "A total of 598 respiratory syncytial virus infections were identified (411 primary, 187 repeat), with 409 determined by antigen assay and 189 by antibody alone (using a "most pragmatic" serologic definition). "
04/01/2014 - "We evaluated the potential clinical utility of an automated near patient molecular assay Verigene Respiratory Virus Plus (RV+) and rapid immunochromatographic antigen tests (RIAT) in the pediatric setting for diagnosis of influenza and respiratory syncytial virus infections when testing was performed by the pediatrician seeing the patient. "
12/01/1989 - "Interferon alfa, infectious virus, and virus antigen secretion in respiratory syncytial virus infections of graded severity."

09/01/2015 - "Respiratory syncytial virus infections in pediatric transplant recipients: A Canadian Paediatric Surveillance Program study."
03/01/2010 - "Low incidence of severe respiratory syncytial virus infections in lung transplant recipients despite the absence of specific therapy."
04/01/1996 - "Respiratory syncytial virus infections in pediatric renal transplant recipients."
01/01/1992 - "Respiratory syncytial virus infections in pediatric liver transplant recipients."
06/18/1988 - "Respiratory syncytial virus infections in adult bone marrow transplant recipients."

01/01/2015 - "Respiratory Syncytial Virus infections are one of the leading causes of severe respiratory diseases that require hospitalization and, in some cases, intensive care. "
04/01/2014 - "Epidemiology and risk factors for severe respiratory syncytial virus infections requiring pediatric intensive care admission in Hong Kong children."
08/01/1979 - "A nosocomial outbreak of respiratory syncytial virus infections involved 8 of 17 infants in an Intensive Care Nursery and one additional infant in the adjoining Newborn Nursery. "
08/01/1979 - "Nosocomial respiratory syncytial virus infections in an intensive care nursery: rapid diagnosis by direct immunofluorescence."
01/01/2014 - "Children with cystic fibrosis are prone to recurrent lung inflammation, bacterial colonisation and subsequent chronic airway disease, putting them at risk for severe respiratory syncytial virus infections requiring intensive care and respiratory support. "

06/01/1997 - "Nosocomial respiratory syncytial virus infections: prevention and control in bone marrow transplant patients."
06/01/1993 - "Finally, consideration is given to infections in immunocompromised children: the effects of respiratory syncytial virus infections in immunosuppressed transplant patients, and prevention and diagnosis of opportunistic infections (including Pneumocystis carinii) in children with human immunodeficiency virus."

03/01/2015 - "Chemotherapy of respiratory syncytial virus infections: the final breakthrough."
02/01/2000 - "Recent progress in antiviral chemotherapy for respiratory syncytial virus infections."

04/01/2008 - "[Nosocomial respiratory syncytial virus infections in three cases in a bone marrow transplantation unit]."